Reaction

Cerebral Venous Thrombosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,800 reports · 31 co-occurring drugs

As of the last recalculation, Cerebral Venous Thrombosis appears in 1,800 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is PEGASPARGASE (PRR 61.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Pegaspargase6361.661.9
Etonogestrel And Ethinyl Estradiol9552.252.5
Drospirenone And Ethinyl Estradiol11130.931.0
Bleomycin Sulfate2224.925.0
Romiplostim3023.423.5
Vincristine Sulfate4216.917.0
Eltrombopag Olamine3316.816.9
Orlistat3515.915.9
Bupropion5013.313.3
Methylprednisolone Acetate913.113.1
Sumatriptan Succinate2511.611.6
Cytarabine5210.310.3
Testosterone2010.010.0
Dutasteride710.010.0
Topiramate709.09.0
Sumatriptan288.68.6
Senna Leaf178.68.6
Heparin Sodium108.48.5
Sennosides 8.6 Mg Tablets158.38.3
Senna158.38.3
Mercaptopurine128.08.1
Ganciclovir77.97.9
Ganciclovir Sodium77.77.7
Amphotericin B87.47.4
Cisplatin426.36.3
Aprepitant95.75.7
Etoposide314.94.9
Acetaminophen, Aspirin (Nsaid) And Caffeine64.14.1
Ixekizumab123.83.8
Ixazomib62.42.4
Levonorgestrel241.41.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.